Interferon-γ plus lipopolysaccharide induction of delayed neuronal apoptosis in rat hippocampus

Neurochemistry International

Volumn 34, Issue 2, 1999, Pages 91-99

  Matsuoka, Yasuji ^a   Kitamura, Yoshihisa ^a   Takahashi, Hideaki ^a   Tooyama, Ikuo ^b   Kimura, Hiroshi ^b   Gebicke Haerter, Peter J ^d   Nomura, Yasuyuki ^c   Taniguchi, Takashi ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c Faculty of Pharmaceutical   (Japan)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; DOSE RESPONSE; ENZYME SYNTHESIS; GRANULAR CELL; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; NERVE CELL; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALIA; HIPPOCAMPUS HIPPOCAMPUS;

EID: 0033021242     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(98)00053-9     Document Type: Article

References (35)

1. Adamson, D.C., Wildemann, B., Sasaki, M., Glass, J.D., McArthur, J.C., Christov, V.I., Dawson, T.M., Dawson, V.L., 1996. Immunologic NO synthase: Elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 274, 1917-1923.
2. Akiyama, H., Itagaki, S., McGeer, P.L., 1988. Major histocompatibility complex antigen expression on rat microglia following epidural kainic acid lesions. J. Neurosci. Res. 20, 147-157.
3. Banati, R.B., Gehrmann, J., Schubert, P., Kreutzberg, G.W., 1993. Cytotoxicity of microglia. Glia 7, 111-118.
4. Benveniste, E.N., 1993. Astrocyte-microglia interactions. In: Murphy, S., (Ed.) Astrocytes: Pharmacology and Function. Academic Press, San Diego, pp. 355-382.
5. Bukrinsky, M.I., Nottet, H.S.L.M., Schmidtmayerova, H., Dubrovsky, L., Flanagan, C.R., Mullins, M.E., Lipton, S.A., Gendelman, H.E., 1995. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: Implications for HIV-associated neurological disease. J. Exp. Med. 181, 735-745.
6. Dawson, T.M., Dawson, V.L., Snyder, S.H., 1992. A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann. Neurol. 32, 297-311.
7. Dawson, V.L., Dawson, T.M., London, E.D., Bredt, D.S., Snyder, S.H., 1991. Nitric oxide mediates glutamates neurotoxicity on primary cortical cultures. Proc. Natl. Acad. Sci. U.S.A. 88, 6368-6371.
8. Dickson, D.W., Lee, S.C., Mattiace, L.A., Yen, S.C., Brosnan, C., 1993. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimers disease. Glia 7, 75-83.
9. Dickson, D.W., 1995. Apoptosis in the Brain: Physiology and pathology. Am. J. Pathol. 146, 1040-1044.
10. Dorheim, M.-A., Tracey, W.R., Pollock, J.S., Grammas, P., 1994. Nitric oxide synthase activity is elevated in brain microvessels in Alzheimers disease. Biochem. Biophys. Res. Commun. 205, 659-665.
11. Finsen, B.R., Jørgensen, M.B., Diemer, N.H., Zimmer, J. 1993. Microglial MHC antigen expression after ischemic and kainic acid lesions of the adult rat hippocampus. Glia 7, 41-49.
12. Frei, K., Siepl, C., Groscurth, P., Bodmer, S., Schwerdel, C., Fontana, A., 1987. Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglia cells. Eur. J. Immunol. 17, 1271-1278.
13. Gavrieli, Y., Sherman, Y., Ben-Sasson, S.A., 1992. Identification of programed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119, 493-501.
14. Hayashi, T., Morimoto, C., Burks, J.C., Kerr, C., Hauser, S.L., 1988. Dual-labeled immunocytochemistry of the active multiple sclerosis lesion: Major histocompatibility complex and activation antigens. Ann. Neurol. 24, 523-531.
15. Hasko, G., Nemeth, Z.H., Szabo, C., Zsilla, G., Salzman, A.L., Vizi, E.S., 1998. Isoproterenol inhibits II-10, TNF-α, and nitric oxide production in RAW 264.7 macrophages. Brain Res. Bull. 45, 183-187.
16. Hasko, G., Szabo, C., Nemeth, Z.H., Kvetan, V., Pastores S.M., Vizi, E.S., 1996. Adenosine receptor agonists differentially regulate IL-10, TNF-α, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J. Immunol. 157, 4634-4640.
17. 2-insensitive but calmodulin-coupling nitric oxide synthase in rat glial cells. J. Neurosci. Res. 43, 235-245.
18. Kitamura, Y., Takahashi, H., Nomura, Y., Taniguchi, T., 1996b. Possible involvement of Janus kinase Jak2 in interferon-γ induction of nitric oxide synthase in rat glial cells. Eur. J. Pharmacol. 306, 297-306.
19. Kitamura, Y., Takahashi, H., Matsuoka, Y., Tooyama, I., Kimura, H., Nomura, Y., Taniguchi, T., 1996c. In vivo induction of inducible nitric oxide synthase by microinjection with interferon-γ and lipopolysaccaride in rat hippocampus. Glia 18, 233-243.
20. Kitamura, Y., Shimohama, S., Ota, T., Matsuoka, Y., Nomura, Y., Taniguchi, T., 1997. Alteration of transcription factors NF-κB and STAT1 in Alzheimers disease brains. Neurosci. Lett. 237, 17-20.
21. Kitamura, Y., Kamoshima, W., Shimohama, S., Nomura, Y., Taniguchi, T., 1998. Nitric oxide donor-induced p53-sensitive cell death is enhanced by Bcl-2 reduction in human neuroblastoma cells. Neurochem. Int. 32, 93-102.
22. McGeer, P.L., Kawamata, T., Walker, D.G., Akiyama, H., Tooyama, I., McGeer, E.G., 1993. Microglia in degenerative neurological disease. Glia 7, 84-92.
23. Mochizuki, H., Goto, K., Mori, H., Mizuno, Y., 1996. Histochemical detection of apoptosis in Parkinsons disease. J. Neurol. Sci. 137, 120-123.
24. Murphy, S., Simons, M.L., Agullo, L., Garcia, A., Feinstein, D.L., Galea, E., Reis, D.J., Minc-Golomb, D., Schwartz, J.P., 1993. Synthesis of nitric oxide in CNS glial cells. Trends. Neurosci. 16, 323-328.
25. Nathan, C., 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6, 3051-3064.
26. Ohshima, H., Brouet, I.M., Bandaletova, T., Adachi, H., Oguchi, S., Iida, S., Kurashima, Y., Morishita, Y., Sugimura, T., Esumi, H., 1992. Polyclonal antibody against an inducible form of nitric oxide synthase purified from the liver of rats treated with Propionibacterium Acnes and lipoloysaccharide. Biochem. Biophys. Res. Commun. 187, 1291-1297.
27. Paxinos, G., Watson, C., 1986. In: Paxinos, G., Watson, C. (Eds). The Rat Brain in Stereotaxic Coordinates, 2nd ed. Academic Press, New York.
28. Petito, C.K., Roberts, B., 1995. Evidence of apoptotic cell death in HIV encephalitis. Am. J. Pathol. 146, 1121-1130.
29. Rao, K., Lund, R.D., 1993. Optic nerve degeneration induces the expression of MHC antigens in the rat visual system. J. Comp. Neurol. 336, 613-627.
30. Rogers, J., Kirby, L.C., Hempelman, S.R., Berry, D.L., McGeer, P.L., Kaszniak, A.W., Zalinksi, J., Cofield, M., Mansukhani, L., Willson, P., Kogan, F., 1993. Clinical trial of indomethacin in Alzheimers disease. Neurology 43, 1609-1611.
31. Smale, G., Nichols, N.R., Brady, D.R., Finch, C.E., Horton, W.E.Jr, 1995. Evidence for apoptotic cell death in Alzheimers disease. Exp. Neurol. 133, 225-230.
32. Suzumura, A., Mezitis, S.G.E., Gonatas, N.K., Silberberg, D.H., 1987. MHC antigen expression on bulk isolated macrophage-microglia from newborn mouse brain: Induction of Ia antigen expression by gamma-interferon. J. Neuroimmunol. 15, 262-278.
33. Tooyama, I., Kimura, H., Akiyama, H., McGeer, P.L., 1990. Reactive microglia express class I and class II major histocompatibility complex antigen in alzheimers disease. Brain Res. 523, 273-280.
34. Traugott, U., 1987. Relevance of class I and class II MHC expressing cells to lesion development. J. Neuroimmunol. 16, 283-302.
35. Widera, G., 1986. Molecular biology of the histocompatibility complex. Science 233, 437-443.